Roche to Present New New OCREVUS data at ECTRIMS advance clinical understanding of underlying progression in multiple sclerosis
Roche announced that new OCREVUS® data are being presented at the 7th Joint European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) –...
AbbVie Receives U.S. FDA Priority Review for Investigational Oral Treatment Elagolix
AbbVie , a research and development based global biopharmaceutical company in cooperation with Neurocrine Biosciences, Inc.announced that the U.S. FDA has granted priority review...
Allergan Presented New Phase 3 Data of Ulipristal Acetate in Women with Uterine Fibroids
Allergan plc presented new analyses of VENUS II, the second of two pivotal Phase 3 clinical trials evaluating the efficacy and safety of ulipristal...
Nicholas Shackley joins to Lead our Pharmaceutical Contract Development and Manufacturers Services Business
In this role Nicholas will lead Johnson Matthey's (JM) custom development and manufacturing offering to pharmaceutical and biotechnology customers who are developing novel therapies...
Alopexx Completes First-In-Man Trial Of Its Novel, Broad-Spectrum Anti-Microbial Vaccine
Alopexx Vaccine LLC announced that it has completed a Phase 1 clinical trial with AV0328, a vaccine targeting the broadly expressed microbial antigen, poly-N-acetyl...
FDA Approval And Launch Of Generic Renvela® (Sevelamer Carbonate) Tablets, 800 Mg announces impax
Impax Laboratories, Inc., a specialty pharmaceutical company, announced it has received final U.S. FDA approval on its ANDA for a generic version of Renvela®...
UK Nod For Gene Therapy, GSK Wins U.S. Shingles Vaccine Approva
GlaxoSmithKline has won U.S. approval for a new and improved shingles vaccine, the second of three key products for which the British drugmaker expects...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...